ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,128Medicare Part D Prescriptions Filled, Including Refills

Rank: 86 out of 1269

$647K Total Retail Price of All Prescriptions

Rank: 69 out of 1269

585 Patients Receiving at Least One Drug in Part D
59%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 585 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

4% of this provider’s 585 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

3% of this provider’s 4,993 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
AMLODIPINE BESYLATE 389 244 1 2
LISINOPRIL 314 150 2 1
FUROSEMIDE 252 145 3 5
SIMVASTATIN 230 141 4 3
HYDROCHLOROTHIAZIDE 222 140 5 10
TRAMADOL HCL 217 102 6 16
METOPROLOL TARTRATE 186 138 7 6
ZOLPIDEM TARTRATE 163 66 8 19
AZITHROMYCIN 142 87 9 42
METFORMIN HCL 141 92 10 9
PRAVASTATIN SODIUM 139 84 11 11
ATORVASTATIN CALCIUM 138 111 12 7
LISINOPRIL-HYDROCHLOROTHIAZIDE 130 81 13 33
IBUPROFEN 126 60 14 73
METOPROLOL SUCCINATE 125 83 15 13
PROMETHAZINE HCL 123 41 R 16 149
LANTUS 108 32 17 39
PANTOPRAZOLE SODIUM 104 57 18 18
RANITIDINE HCL 103 52 19 27
OMEPRAZOLE 101 36 20 8
ATENOLOL 100 66 21 14
NIFEDICAL XL 99 82 22 138
GLIPIZIDE 97 74 23 37
CLONIDINE HCL 96 43 24 51
AMOXICILLIN 93 46 25 129
LEVOTHYROXINE SODIUM 92 65 26 4
NEXIUM 79 46 27 41
VENTOLIN HFA 76 44 28 100
CIPROFLOXACIN HCL 72 43 29 66
CARVEDILOL 72 40 29 29
POTASSIUM CHLORIDE 71 46 31 26
PREDNISONE 71 36 31 45
WARFARIN SODIUM 69 44 33 12
TRAZODONE HCL 68 14 34 36
SERTRALINE HCL 68 40 34 23
NIFEDIPINE ER 67 43 36 65
FAMOTIDINE 67 34 36 85
INSULIN SYRINGE 66 23 38 87
SPIRONOLACTONE 65 32 39 77
NAPROXEN 64 15 40 107
GABAPENTIN 62 37 41 17
HUMALOG 58 14 42 109
OXYCODONE HCL 58 25 S2 42 34
PHENYTOIN SODIUM EXTENDED 57 15 44 137
CRESTOR 56 33 45 25
GLYBURIDE 54 51 R 46 94
ADVAIR DISKUS 53 29 47 46
NAMENDA 53 47 47 38
TAMSULOSIN HCL 52 23 49 31
PLAVIX 52 46 49 47
CYCLOBENZAPRINE HCL 52 24 R 49 93
PROAIR HFA 52 22 49 61
CITALOPRAM HBR 51 13 53 21
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 13, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.